about
Grafting of a model protein on lactide and caprolactone based biodegradable films for biomedical applications.An academic, clinical and industrial update on electrospun, additive manufactured and imprinted medical devices.Functionalised collagen spheres reduce H2O2 mediated apoptosis by scavenging overexpressed ROS.Effect of bioactive glass particles on osteogenic differentiation of adipose-derived mesenchymal stem cells seeded on lactide and caprolactone based scaffolds.Design, Degradation Mechanism and Long-Term Cytotoxicity of Poly(L-lactide) and Poly(Lactide-co-ϵ-Caprolactone) Terpolymer Film and Air-Spun Nanofiber Scaffold.Crystallization and its effect on the mechanical properties of a medium chain length polyhydroxyalkanoate.Antioxidant functionalized polymer capsules to prevent oxidative stress.Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers.Polyhydroxyalkanoate/carbon nanotube nanocomposites: flexible electrically conducting elastomers for neural applications.Effects of Polydopamine Functionalization on Boron Nitride Nanotube Dispersion and Cytocompatibility.A new generation of poly(lactide/ε-caprolactone) polymeric biomaterials for application in the medical field.A study of the mechanical properties and cytocompatibility of lactide and caprolactone based scaffolds filled with inorganic bioactive particles.Supramolecular evolution over an initial period of biodegradation of lactide and caprolactone based medical (co)polyestersTensile behavior and dynamic mechanical analysis of novel poly(lactide/δ-valerolactone) statistical copolymersEffect of bioactive glass particles on the thermal degradation behaviour of medical polyestersEffects of chain microstructures and derived crystallization capability on hydrolytic degradation of poly(l-lactide/ε-caprolactone) copolymersImprovement of thermal stability and mechanical properties of medical polyester composites by plasma surface modification of the bioactive glass particles
P50
Q33460757-72620714-067A-4E1D-AB89-4C3615749680Q38537935-0127DAFB-8801-473F-967B-74B206FBCEB7Q38759342-7936AB34-3D19-4060-A308-B4812F00FEE0Q40835615-0655BC18-56D1-42A8-B745-989A51E43CA6Q40853016-9772C15B-C234-4AD0-938B-0BC50B67EBFFQ44992596-D20E523F-7918-41D2-AF34-D2045463C8E8Q47233950-B42F2969-8570-403E-A27A-14426B5B8D35Q47830574-86A05153-0B60-418C-A09B-58DDEE4BF4F1Q50220016-56D4FDDD-4DFA-4DC7-BA0A-703AFA24A3DAQ51805217-210E137C-AB1B-45D6-8FC5-9A9B7FAB41F5Q52645409-99CB633E-6678-49BB-8A0C-071F09FBAE79Q53491058-D8A87B9A-932D-4D9C-8AD6-2AB6DCC0B8B0Q60165981-1E332E46-4392-4A20-966A-85D0ADE6F103Q60165984-F901F5B5-A4E2-41E5-BDA9-B3F5D2ABD1A2Q60165986-141D8C33-2B43-4EFF-AEB1-7A52A6A68A69Q60165988-D80CE5B5-2BA4-4E03-8317-5AF1160368E6Q60165990-C7AEAB38-1369-4831-93D5-DD14D68609EF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A Larrañaga
@ast
A Larrañaga
@en
A Larrañaga
@es
A Larrañaga
@nl
A Larrañaga
@sl
type
label
A Larrañaga
@ast
A Larrañaga
@en
A Larrañaga
@es
A Larrañaga
@nl
A Larrañaga
@sl
prefLabel
A Larrañaga
@ast
A Larrañaga
@en
A Larrañaga
@es
A Larrañaga
@nl
A Larrañaga
@sl
P106
P31
P496
0000-0002-2123-6069